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Changes in transcription factor binding sequences result in correlated changes in chromatin
composition locally and at sites hundreds of kilobases away. New studies demonstrate that this
concordance is mediated via spatial chromatin interactions that constitute regulatory modules of
the human genome.The majority of disease-causing genetic
variations occur in non-coding regulatory
sequences that presumably control the
transcriptional output of target genes.
Such enhancer regions and their encom-
passed transcription factor (TF) binding
sites display high variability among indi-
viduals. Disease-associated sequence
variations (quantitative trait loci; QTL)
alter local chromatin states and affect
binding of transcription factors, DNase
I hypersensitivity (DHS), nucleosome
positioning, histone modifications, and,
ultimately, enhancer activity (McVicker
et al., 2013; Kasowski et al., 2013; Kilpinen
et al., 2013). Surprisingly, such correlated
changes in chromatin state are not limited
to the local environment but can, in some
cases, affect loci up to 200 kb distal to
the QTL (McVicker et al., 2013; Kilpinen
et al., 2013). Previouswork has suggested
that chromatin architecture may be in-
volved in this phenomenon (e.g.,McVicker
et al., 2013); however, definitive proof and
functional understanding of this process
had been missing. In this issue, Waszak
et al. (2015) and Grubert et al. (2015)
explain such coordinated chromatin vari-
ability in light of the three-dimensional
(3D) organization of our genome.
The authors use human lymphoblastoid
cell lines to generate ChIP-seq profiles
for the histone modifications H3K4me3
(demarcating promoters), H3K4me1 (en-
hancers), and H3K27ac (promoters and
enhancers), as well as for the regulatory
TF PU.1 and RNA polymerase II, which
they integrate with DHS and gene ex-
pression data. Both studies demonstrate
that distinct, and often disease-relevant,
genetic variations, especially at the level
of TF motifs, can serve as QTLs, causing
local and distal allelic variation in histone
marks, chromatin accessibility, and/or942 Cell 162, August 27, 2015 ª2015 Elseviegene expression. Subsequently, they
compare theobservedmolecular associa-
tions with previously published (Rao et al.,
2014) and newly generated chromatin
conformation data (Grubert et al., 2015)
to show that long-range genetic regulation
of chromatin variation often involves
specific 3D contacts between pairs of
regulatory modules (Figure 1). Regions of
coordinated chromatin variation thereby
form an intricate network of enhancer-
enhancer, enhancer-promoter, and pro-
moter-promoter interactions, which are
spatially organized into ‘‘variable chro-
matin modules’’ (VCMs; Waszak et al.,
2015) up to several hundred kilobases in
size. Chromatin QTLs haveweaker effects
on distal interaction partners than on local
sequences, consistent with the idea that
distal interactions, as observed by chro-
matin conformation capture techniques,
represent transient events.
How do these regulatory micro-envi-
ronments fit into our current understand-
ing of chromatin organization? Recent
studies on genome-wide chromatin topol-
ogy have revealed the existence of mega-
base-sized ‘‘topologically associated
domains’’ (TADs)—chromosomal regions
within which sequences preferentially
contact each other. Most TADs appear
conserved across cell types and species
and can be further divided into topological
subdomains that show a median size of
nearly 200 kb. These chromosomal do-
mains have been described to display
distinct patterns of histone marks (Rao
et al., 2014) and exert unique regulatory
activity (Symmons et al., 2014), indicating
that they demarcate not only spatial but
also functional entities. Waszak et al.
and Grubert et al. now show that genetic
control of chromatin states occurs within
TADs and their smaller subdomains.r Inc.Both studies also report that histone
QTLs (hQTLs; affecting the local and distal
chromatin state) are enriched in common
(auto-)immune disease variants, consis-
tentwith thecell typeunder study,a finding
that emphasizes the medical relevance of
this phenomenon. Consequentially, Gru-
bert et al. andWaszak et al. propose using
chromatin QTL mapping in genome-wide
association studies (GWAS) tohelp identify
putative target genes of disease-associ-
ated variants. It is still unclear whether
many disease-associated single-nucleo-
tide polymorphisms in non-coding DNA
are disease causative (‘‘drivers’’) or merely
act as ‘‘passengers’’ and how, exactly,
they alter genome functioning. Paired
chromatin variation between an enhancer
near or at aGWAShit andadistal promoter
may help identify the disease-relevant
gene and elucidate the regulatory network
driving its expression.
While these findings will certainly launch
new possibilities to assign function to
the collectionofGWAShits,which remains
largely descriptive, both papers show that
concertedvariation inchromatin statesbe-
tweendistal sites is linked to, and probably
caused by, their spatial interactions. The
advantage of chromatin QTL mapping
over analysis of enhancer-promoter in-
teractions by chromosome conformation
capture techniques therefore remains to
be determined. Several recent papers
have demonstrated the usefulness of
high-resolution chromatin contact maps
to link human GWAS variants to target
genes (e.g., Dixon et al., 2015). The ever
increasing resolution of Hi-C maps can
serve to first identify the (sub-)TADencom-
passing the risk variant. The genes co-
occupying this domain are prime candi-
date target genes. Analysis of chromatin
loops formed by their gene promoters
Figure 1. Genomic Variants Alter Local and Distal Chromatin
Achange in a transcription factor (TF) binding site (quantitative trait locus [QTL] indicatedbyabluecross; TF
shown in red) can result in altered affinities and consequentially dynamic changes in the local chromatin
composition—for example, by affecting the rate of recruitment of modifying enzymes such as histone
methyltransferases (HMTs). (Depicted here are changes in H3K4 mono- and trimethylation; however
H3K27ac, DNase I hypersensitivity, and recruitment of further TFs can also be affected.) Eventually, altered
chromatin states can enhance or reduce RNA polymerase II (Pol II) recruitment to nearby promoters and
therefore affect transcriptional output. Grubert et al. (2015) andWaszak et al. (2015) demonstrate thatQTLs
can also affect chromatin composition concordantly at distal but spatially interacting genomic sequences,
thereby encompassing subdomains of correlated histone marks at the level of tens to hundreds of kilo-
bases. A hypothetical cohesin-mediated loop (orange) is shown with potential interacting proteins (green).with the regulatory modules at or near the
GWAShitmaysubsequently enable identi-
fication of disease-relevant genes.
As the authors propose, hQTL mapping
can also reveal the cell type implicated in
disease, a first step often needed to un-
cover relevant target genes. GWASbenefit
from the tissue invariance of inherited ge-
netic variation, but disease-associated
SNPs identified in geneticmaterial of white
blood cells, for instance, will often be func-
tional only in a given other tissue and
possibly at another stage of development.
Their chromatin makeup is not tissue
invariant and can likely reveal the cell type
in which they exert their action, in which
case distal chromatin QTL mapping may
uncover the linked, disease-relevant gene.
Practically, this seems an ambitious
enterprise, as it would require the isolation
of relatively pure populations of a plethora
of cell types from at least dozens (the
current two studies) and probably even
more individuals, which could become
evenmore challenging in the investigation
of developmental diseases. In the future,
systematic analysis of organoids derived
from many individuals may enable crea-
tion of an hQTL reference database for
various tissues and cell types. However,
to cause phenotypic variability, sequencealterations are expected to affect target
gene expression, and eQTL (variants
affecting gene expression) data sets of
these cell types may therefore prove
more meaningful. A combination of eQTL
and high-resolution chromatin contact
maps across tissues might eventually be
the most powerful strategy to identify
GWAS target genes. Recently, 55%–
75% of chromatin loops have been found
to be conserved between cell types (Rao
et al., 2014), and further analyses in pri-
mary cells will likely refine this estimate.
However, if the majority of enhancer-pro-
moter loops are indeed pre-formed, or
‘‘permissive,’’ (existing acrossmultiple tis-
sues), rather than formed de novo upon
‘‘instructive’’ tissue-specific cues (de
Laat and Duboule, 2013), it might not be
necessary to create contactmapsof every
single cell type in order to identify putative
target genes contacting risk variants.
Regardless of whether or not chromatin
QTLs prove instrumental in detecting new
disease genes and networks, the struc-
tural micro-environments described in
these two studies provide an explanation
for regulatory variability in the absence of
proximal sequence change. The genetic
status of one regulatorymodule can affect
the chromatin state of a proximal module,Cell 16as it has recently been demonstrated for
Polycomb domains in Drosophila, where
recruitment of Polycomb group proteins
to binding sites, even if weak, is substan-
tially enhanced if they are linearly close
to other strong Polycomb binding sites
(Schuettengruber et al., 2014). The studies
by Waszak et al. and Grubert et al. now
demonstrate that such cooperative ef-
fects are also at play at distant but con-
tacting genomic loci and represent a new
regulatory dimension of complementary
chromatin states.
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